Ildong Pharmaceutical, “Negotiating entry into the Indonesian market for the treatment of chronic disease” |

Ildong Pharmaceutical (CEO Yoon Woong-seop) announced on the 28th that it is holding a separate meeting with officials from the Indonesian Ministry of Health who visited Korea to commemorate the 50th anniversary of Korea-Indonesia diplomatic relations and discuss business exchanges.

news/photo/202303/3004232_3004645_418.jpg?resize=800%2C604&ssl=1" alt="인도네시아 보건부 부디 구나디 사디킨 장관(왼쪽에서 다섯 번째)과 로날두스 무주르 차관(왼쪽에서 세 번째), 일동제약 최고운영책임자 서진식 사장(왼쪽에서 여섯 번째)을 비롯한 양측 관계자들이 미팅 후 기념 촬영을 하고 있다." width="800" height="604" layout="responsive" class="amp_f_img" data-recalc-dims="1"/>
Indonesian Health Minister Budi Gunadi Sadikin (fifth from left), Deputy Minister Ronaldus Mujur (third from left), and Ildong Pharmaceutical Chief Operating Officer Seo Jin-sik (sixth from left) and other officials drew both sides of a commemorative photo after the meeting is done

The meeting was attended by officials from both sides, including Indonesian Health Minister Budi Gunadi Sadikin, Vice Minister Ronaldus Mujur, and Ildong Pharmaceutical Chief Operating Officer (COO) Seo Jin-shik.

Currently, Ildong Pharmaceutical conducts business in Indonesia related to its finished medicines and raw materials.

Ildong Pharmaceutical said it met with officials from the Indonesian health authorities and discussed issues on which both sides could cooperate in the medical, pharmaceutical and healthcare fields.

In particular, it was explained that they shared views on strategies for entering the Indonesian market and commercialization plans for raw materials and products using probiotics as well as pharmaceuticals, including complex drugs for chronic diseases owned by Ildong Pharmaceutical.

In addition, along with Ildong Pharmaceutical’s new drug research and development status and strategy, major pipelines such as type 2 diabetes treatment, gastric acid-related gastric treatment, and non-alcoholic steatohepatitis (NASH) treatment were introduced.

An official from Ildong Pharmaceutical said, “Indonesia is a country with the 4th largest population in the world and an important center for the Southeast Asian economy, with great marketability and potential.”


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.